MetLife MET Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 4.7%+0.3pp | 4.4%-1.0pp | 5.3%-0.5pp | 5.9%-0.3pp | 6.1%-0.1pp | |
| Returns | ||||||
| Return on equity | 13.2%+1.1pp | 12.1%-0.7pp | 12.8%-2.8pp | 15.6%-0.5pp | 16.1%+0.7pp | |
| Return on assets | 0.5%0.0pp | 0.5%-0.1pp | 0.5%-0.1pp | 0.6%0.0pp | 0.7%0.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×0.0× | 0.6×0.0× | 0.5×0.0× | 0.6×0.0× | 0.5×-0.1× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Valuation | ||||||
| Market capitalization | $46.11B-11.3% | $52.01B-5.0% | $54.78B+2.4% | $53.48B-2.2% | $54.7B-3.5% | |
| Enterprise value | $38.28B-16.7% | $45.95B-8.5% | $50.22B+6.7% | $47.05B-2.9% | $48.45B-9.0% | |
| Price / earnings | 12.7×-2.7× | 15.4×+1.1× | 14.3×+1.8× | 12.5×+0.3× | 12.1×-0.7× | |
| Price / sales | 0.6×-0.1× | 0.7×-0.1× | 0.8×0.0× | 0.7×0.0× | 0.7×-0.1× | |
| Price / book | 1.7×-0.1× | 1.8×-0.1× | 1.9×0.0× | 1.9×-0.1× | 2×-0.1× | |
| EV / sales | 0.5×-0.1× | 0.6×-0.1× | 0.7×+0.1× | 0.6×0.0× | 0.7×-0.1× | |
| Earnings yield | 7.8%+1.4pp | 6.5%-0.5pp | 7%-1.0pp | 8%-0.2pp | 8.2%+0.4pp | |
| Dividend yield | 3.3%+0.4pp | 2.9%+0.1pp | 2.8%-0.1pp | 2.8%+0.1pp | 2.8%+0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do MetLife's ratios come from?
- Every ratio is computed from MetLife's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
